002317 眾生藥業
按盤價 
21.460 -0.370 (-1.695%)
21.460 -0.370 (-1.695%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.429 | 6.917 | -7.234 | 6.534 | 8.973 |
| 總資產報酬率 ROA (%) | 1.907 | 5.162 | -4.981 | 4.304 | 6.032 |
| 投入資產回報率 ROIC (%) | 2.164 | 5.840 | -5.559 | 4.798 | 6.656 | 邊際利潤分析 |
| 銷售毛利率 (%) | 57.287 | 56.119 | 56.034 | 58.596 | 64.857 |
| 營業利潤率 (%) | 17.972 | 11.824 | -11.346 | 11.443 | 13.985 |
| 息稅前利潤/營業總收入 (%) | 18.698 | 11.548 | -13.255 | 11.509 | 15.901 |
| 淨利潤/營業總收入 (%) | 15.703 | 10.572 | -15.156 | 9.573 | 11.784 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 93.476 | 100.137 | -71.135 | 111.068 | 88.538 |
| 價值變動淨收益/利潤總額(%) | -8.251 | -0.982 | -1.980 | -14.702 | 7.290 |
| 營業外收支淨額/利潤總額(%) | 4.675 | -0.578 | 16.652 | -5.314 | -1.618 | 償債能力分析 |
| 流動比率 (X) | 4.135 | 4.237 | 2.877 | 3.901 | 2.918 |
| 速動比率 (X) | 3.709 | 3.729 | 2.510 | 3.388 | 2.484 |
| 資產負債率 (%) | 20.439 | 19.099 | 27.791 | 29.927 | 33.917 |
| 帶息債務/全部投入資本 (%) | 6.745 | 3.654 | 14.226 | 10.781 | 17.491 |
| 股東權益/帶息債務 (%) | 1,300.641 | 2,476.886 | 554.749 | 696.408 | 409.311 |
| 股東權益/負債合計 (%) | 381.033 | 414.223 | 253.650 | 225.383 | 189.029 |
| 利息保障倍數 (X) | -120.123 | -55.285 | -37.051 | 17.900 | 7.436 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 82.000 | 78.910 | 73.953 | 67.718 | 66.894 |
| 存貨周轉天數 (天) | 121.400 | 131.182 | 159.599 | 166.773 | 178.616 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
